-
Something wrong with this record ?
ADMET parameters of tacrine and its metabolites confirm unsuitability of Sus scrofa f. domestica model to study tacrine-associated hepatotoxicity
M. Novak, J. Bureš, V. Radochová, J. Pejchal, L. Prchal, O. Soukup
Language English Country Ireland
Document type Journal Article
- MeSH
- Biotransformation MeSH
- Cholinesterase Inhibitors toxicity pharmacokinetics MeSH
- Liver * drug effects metabolism pathology MeSH
- Chemical and Drug Induced Liver Injury * metabolism pathology MeSH
- Humans MeSH
- Swine MeSH
- Sus scrofa MeSH
- Tacrine * pharmacokinetics toxicity metabolism analogs & derivatives MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Tacrine, the first approved drug against Alzheimer's disease (AD), was withdrawn from clinical use due to serious adverse effects. The main concern was the human hepatotoxicity, stemming probably from the liver biotransformation and clinically manifested as hepatocellular necrosis, and lobular hepatitis. Concerning the biotransformation, 7-OH-tacrine metabolite is generally suspected of being a precursor of toxic quinone methide, which binds to intracellular -SH proteins and/or depletes intracellular glutathione, and by that probably causes the hepatotoxicity. However, to study these toxic effects, proper animal model is needed to monitor the interspecies differences of metabolism. To fully describe in vivo ADMET parameters of tacrine, five experimental pigs (Sus scrofa f. domestica), as the most physiologically human-like in vivo model showing similar tacrine biotransformation, were used. We studied tacrine and its metabolites ADMET characteristics after both acute i.g. single dose and chronic 42 days p.o daily dose administration of 200 mg of tacrine. Tacrine and its two major metabolites show Tmax in plasma of 360 min, so the absorption is much slower than in human (Tmax = 120 min) and are primarily distributed to the gastro-intestinal tract and CNS. Furthermore, due to the lower activity of CYP1A2 in pigs, tacrine is biotransformed much less efficiently than in humans. This study showed that tacrine accumulates only in adipose tissue, and organ histology and plasma biochemistry assessment revealed no signs of hepatotoxicity even after chronic tacrine administration. Pigs are therefore an unsuitable human-like animal model for evaluating tacrine toxicity.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015132
- 003
- CZ-PrNML
- 005
- 20250731090759.0
- 007
- ta
- 008
- 250708e20250503ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cbi.2025.111548 $2 doi
- 035 __
- $a (PubMed)40319996
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Novak, M $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic
- 245 10
- $a ADMET parameters of tacrine and its metabolites confirm unsuitability of Sus scrofa f. domestica model to study tacrine-associated hepatotoxicity / $c M. Novak, J. Bureš, V. Radochová, J. Pejchal, L. Prchal, O. Soukup
- 520 9_
- $a Tacrine, the first approved drug against Alzheimer's disease (AD), was withdrawn from clinical use due to serious adverse effects. The main concern was the human hepatotoxicity, stemming probably from the liver biotransformation and clinically manifested as hepatocellular necrosis, and lobular hepatitis. Concerning the biotransformation, 7-OH-tacrine metabolite is generally suspected of being a precursor of toxic quinone methide, which binds to intracellular -SH proteins and/or depletes intracellular glutathione, and by that probably causes the hepatotoxicity. However, to study these toxic effects, proper animal model is needed to monitor the interspecies differences of metabolism. To fully describe in vivo ADMET parameters of tacrine, five experimental pigs (Sus scrofa f. domestica), as the most physiologically human-like in vivo model showing similar tacrine biotransformation, were used. We studied tacrine and its metabolites ADMET characteristics after both acute i.g. single dose and chronic 42 days p.o daily dose administration of 200 mg of tacrine. Tacrine and its two major metabolites show Tmax in plasma of 360 min, so the absorption is much slower than in human (Tmax = 120 min) and are primarily distributed to the gastro-intestinal tract and CNS. Furthermore, due to the lower activity of CYP1A2 in pigs, tacrine is biotransformed much less efficiently than in humans. This study showed that tacrine accumulates only in adipose tissue, and organ histology and plasma biochemistry assessment revealed no signs of hepatotoxicity even after chronic tacrine administration. Pigs are therefore an unsuitable human-like animal model for evaluating tacrine toxicity.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a takrin $x farmakokinetika $x toxicita $x metabolismus $x analogy a deriváty $7 D013619
- 650 12
- $a játra $x účinky léků $x metabolismus $x patologie $7 D008099
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a Sus scrofa $7 D034421
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a lékové postižení jater $x metabolismus $x patologie $7 D056486
- 650 _2
- $a biotransformace $7 D001711
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a cholinesterasové inhibitory $x toxicita $x farmakokinetika $7 D002800
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bureš, J $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Radochová, V $u Vivarium, Military Faculty of Medicine, University of Defence, Trebeska 1575, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Pejchal, J $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic; Department of Toxicology and Military Pharmacy, Military Faculty of Medicine, University of Defence, Trebeska 1575, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Prchal, L $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Soukup, O $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic. Electronic address: ondrej.soukup@fnhk.cz
- 773 0_
- $w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 416 (20250503), s. 111548
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40319996 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731090753 $b ABA008
- 999 __
- $a ok $b bmc $g 2366166 $s 1252257
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 416 $c - $d 111548 $e 20250503 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
- LZP __
- $a Pubmed-20250708